Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy.

Authors

Daniela J Conrado
Jane Larkindale
Alexander Berg
Micki Hill
Jackson Burton
Keith R Abrams
Richard T Abresch
Abby Bronson
Douglass Chapman
Michael Crowther
Tina Duong
Heather Gordish-Dressman, George Washington University
Lutz Harnisch
Erik Henricson
Sarah Kim
Craig M McDonald
Stephan Schmidt
Camille Vong
Xiaoxing Wang
Brenda L Wong
Florence Yong
Klaus Romero

Document Type

Journal Article

Publication Date

5-24-2019

Journal

Journal of pharmacokinetics and pharmacodynamics

DOI

10.1007/s10928-019-09642-7

Comments

Epub ahead of print

APA Citation

Conrado, D., Larkindale, J., Berg, A., Hill, M., Burton, J., Abrams, K., Abresch, R., Bronson, A., Chapman, D., Crowther, M., Duong, T., Gordish-Dressman, H., Harnisch, L., Henricson, E., Kim, S., McDonald, C., Schmidt, S., Vong, C., Wang, X., Wong, B., Yong, F., & Romero, K. (2019). Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy.. Journal of pharmacokinetics and pharmacodynamics, (). http://dx.doi.org/10.1007/s10928-019-09642-7

Peer Reviewed

1